Fund Name | CannaFi Fund PCC Domicile Gibraltar |
Fund Description | A closed ended EIF (Experienced Investor Fund) structured as a PCC (Protected Cell Company) |
Investment Director | CannaFi Group Ltd |
First Cell Target Fund Size | £50million |
Investment Objectives | Long term capital growth by investing in legal cannabis companies found in developing markets |
Investment Size | Series A & B rounds £1m - £5m average investment per private company. 50% reserved for follow-on financing rounds |
Investments | 20 total fund investments, no ore than 15 investments per continent and 5 investments per country |
Product Categories | Medical, pharmaceutical, wellness edibles/beverages, supplements & cosmetics. Drug discovery, nootropics, CBD and clinics |
Hurdle rate | 7% per annum |
Expected Returns | 30% gross IRR |
Minimum Investment | £50,000 |
Investment Period | Maximum 5 years |
Term | 5 years |
GP Performance Fee | 20% after return of contributed capital |
Management Fee | 2% per annum |
Organizational Expenses | Not to exceed 2% |